Profiles, antioxidative and ACE inhibitory activity of peptides released from fermented buttermilk before and after simulated gastrointestinal digestion

Bioactive peptides, released from buttermilk by fermentation and/or gastrointestinal proteases, may have health promoting effects. Thus, a comprehensive analysis of the peptide fraction of fermented buttermilk, before and after different phases of simulated gastrointestinal digestion, was performed using ultra high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS). Results showed that digestion simulation substantially changed the peptide profile of fermented buttermilk. A total of 81, 120 and 46 peptides were identified in fermented buttermilk, its gastric and intestinal digests, respectively. These peptides released mostly from beta-casein followed by alpha s1-casein, kappa-casein and beta-lactoglobulin. In addition, 14 peptides released from milk fat globule membrane proteins (lactadherin, butyrophilin and GlyCAM-1). Bioactivity, mainly angiotensin converting enzyme (ACE) inhibitory activity, has been reported before for only 54 of the detected peptides. Radical scavenging, ferric reducing and ACE inhibitory activities of fermented buttermilk peptides increased significantly after digestion, indicating promotion in fermented buttermilk-peptide bioactivity by gastrointestinal digestion.

Automated summary

A comprehensive analysis of the peptide fraction of fermented buttermilk was conducted using UHPLC-ESI-MS/MS before and after simulated gastrointestinal digestion. Results showed significant changes in the peptide profile of fermented buttermilk after digestion. A total of 81, 120, and 46 peptides were identified in fermented buttermilk, its gastric and intestinal digests, respectively. The bioactivity of fermented buttermilk peptides, mainly ACE inhibitory activity, increased significantly after digestion.